Clinical Trial Update: Metabolic Outcomes in Patients With Prolactinomas Under Dopamine Agonist Treatment [Phase 4]

View source ↗

Summary

Phase 4 clinical trial examining metabolic outcomes in prolactinoma patients on dopamine agonist therapy. Recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prolactinoma

Snippet

Sponsor: University Hospital, Basel, Switzerland | Conditions: Prolactinoma | Phase 4 | Status: RECRUITING